Close
ACHEMA MIDDLE EAST 2026

AAV Gene Therapy CDMOs Shaping The Future With A $2.57B Goal

The global market for cell and gene therapy biomanufacturing Contract Development and Manufacturing Organizations (CDMOs), with a specific focus on Adeno-Associated Virus (AAV), witnessed...

Reimagining Pharma Supply Chain in a Multi-Tier Supplier Ecosystem

In late 2020, drug manufacturer Pfizer had to scale back on its earlier-announced targets for Covid-19 vaccine production when it found that raw materials...

Understanding HCP Usage of Technology in a Post-Pandemic World through Hidoc

The COVID-19 pandemic has revolutionized the health care system in India by bringing in multiple digital health technologies as the new normal. As a...

The 6-Step Strategy for a Smart, Efficient Clinical Batch

For injectable medications, the shift from preclinical to clinical development is one of the most important transitions in the development cycle. It’s the point...

Trends in new medications demand innovative patient-friendly drug delivery systems

In today’s biopharmaceutical industry, manufacturing partners recommend pharma and biotech companies to begin their injectable drug development with the end in mind. Drug-owners should...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...